The Food and Drug Administration says its ongoing safety review of the nation's main abortion pill will continue into next ...
The FDA faces a court-ordered deadline today to update a federal judge in Louisiana on the status of its ongoing review of the abortion drug mifepristone, potentially shedding light on a secretive ...
The number of pharmacies stocking the MS-2 Step medication increased from 2,228 to 4,107 after rules relaxed in 2023 ...
A federal judge in Louisiana ordered the agency to provide an update on its safety study as part of a lawsuit seeking to ...
The Food and Drug Administration (FDA) won’t publish its safety review of the abortion drug mifepristone until March, it disclosed in a Wednesday court filing, adding that it won’t impose any new ...
The state Department of Health says it will soon destroy its reserve of misoprostol pills, which is enough for 12,500 doses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results